Insider / MCKESSON CORP
Dunsire Deborah
Director at MCKESSON CORP
- Company
- MCKESSON CORP
- First filing on record
- May 18, 2026
- Latest trade on record
- July 22, 2026
- SEC filings
- EDGAR ↗
Dunsire Deborah, Director at MCKESSON CORP, has disclosed 3 transactions in MCK, RARE since May 18, 2026: 0 purchases (0 open-market buys) and 0 sales, worth about $0 at the reported prices. The latest was filed July 23, 2026, 1 day after the trade.
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
In the last 12 months Dunsire Deborah reported 3 transactions that were neither a purchase nor a sale, such as stock awards, option exercises or shares withheld for tax.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
0 of 2 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| A | Grant or award | 3 | 22,086 | — |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 3 | 0 | 0 |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| MCK | Other A | July 22, 2026 | July 23, 2026 | 1d | 277 | — | — | derivative | Form 4 ↗ | |
| RARE | Other A | May 14, 2026 | May 18, 2026 | 4d | 14,058 | — | — | derivative | Form 4 ↗ | |
| RARE | Other A | May 14, 2026 | May 18, 2026 | 4d | 7,751 | — | — | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| July 23, 2026 | Form 4 | 0000927653-26-000200 | 1 | published | EDGAR ↗ |
| May 18, 2026 | Form 4 | 0001193125-26-229222 | 2 | published | EDGAR ↗ |
Other insiders at MCKESSON CORP
- Wilson-Thompson Kathleen Director 45 rows
- TYLER BRIAN S. Chief Executive Officer 24 rows
- Lau Michele EVP and Chief Legal Officer 18 rows
- Smith LeAnn B EVP & Chief HR Officer 17 rows
- Fraga Francisco EVP, CIO and CTO 16 rows
- Horn Howard Chief Financial Officer 16 rows
- Rodgers Thomas L EVP, Chief Strategy & BDO 16 rows
- Rutledge Napoleon B JR SVP, Controller & CAO 16 rows
- Vitalone Britt J. EVP & CFO 15 rows
- Parschauer Karah Herdman EVP and Chief Legal Officer 8 rows
Everyone on file, with contracts and lobbying under the company's name: MCKESSON CORP.
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 2 | 3 | May 18, 2026 | July 23, 2026 | Form 4 list on EDGAR |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.